相关实验视频

Updated: Feb 28, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

内皮相关的lncRNAs与早期发病的STEMI的关联:一个病例对照研究

Elham Madandar¹, Yasaman Zarinfar², Mohammad Hassan Namazi¹

¹Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Journal of cardiovascular translational research

|February 27, 2026

概括

新的研究表明,特定的长非编码RNA (lncRNAs) 可能作为早期ST段升高心肌梗塞 (STEMI) 的生物标志物. 在年轻的STEMI患者中观察到MANTIS和NORAD的水平降低,这表明它们的潜在诊断价值.

科学领域:

心脏病学心脏病学
分子生物学分子生物学
生物标志物发现发现

背景情况:

在50岁以下的个体中,早期开始的ST段升高心肌梗塞 (STEMI) 是一个日益严重的临床问题.
改善早期诊断标志物对于在年轻的STEMI患者及时干预至关重要.
长非编码RNAs (lncRNAs) 越来越多地被认为在心血管疾病中的作用.

研究的目的:

研究特定的内皮相关 lncRNAs (MANTIS,NORAD,RNCR3,SENCR) 作为早期STEMI的诊断生物标志物的潜力.
与年龄相匹配的对照组相比,评估年轻STEMI患者中这些lncRNAs的表达水平.

主要方法:

一项涉及200名年轻STEMI患者和200名健康对照者的病例控制研究.
实时定量聚合酶连锁反应 (RT-qPCR) 用于测量血液样本中的lncRNA表达.
进行了统计分析,包括曲线下面积 (AUC) 的计算,以评估诊断准确度.

主要成果:

与对照组相比,在STEMI患者中发现NORAD和MANTIS的表达水平明显较低 (p < 0.001).
曼蒂斯显示出高诊断潜力,AUC为0.92,而NORAD显示出中等潜力,AUC为0.68.
两组之间没有观察到SENCR和RNCR3表达的显著差异.

结论:

曼蒂斯和诺拉德的下调表明它们作为早期开始的STEMI的新生物标志物的潜在实用性.
特别是曼蒂斯可以帮助风险分层,并指导年轻STEMI患者的治疗策略.
建议对更大,更多样化的群体进行进一步的验证研究,以证实这些发现.

关键词:

生物标志物生物标志物早期发生的STEMI 内皮质功能障碍内皮质功能障碍这是一个LncRNARNA.曼蒂斯 (Mantis) 是一个山地.美国北方防务部 (NORAD) 负责这些.这是一个声音.

更多相关视频

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Published on: January 23, 2009

相关概念视频

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...